Polycythemia vera and Myelodysplastic syndrome

Summary:

Myelodysplastic syndrome is found among people with Polycythemia vera, especially for people who are female, 60+ old.

The study analyzes which people have Myelodysplastic syndrome with Polycythemia vera. It is created by eHealthMe based on reports of 8 people who have Polycythemia vera from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 24, 2022

8 people who have Polycythemia Vera and Myelodysplastic Syndrome are studied.


What is Polycythemia vera?

Polycythemia vera (blood disorder in which the bone marrow makes too many red blood cells) is found to be associated with 552 drugs and 321 conditions by eHealthMe.

What is Myelodysplastic syndrome?

Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged) is found to be associated with 1,337 drugs and 997 conditions by eHealthMe.

Number of Myelodysplastic syndrome in Polycythemia vera reports submitted per year:

Would you have Myelodysplastic syndrome when you have Polycythemia vera?

Gender of people who have Polycythemia Vera and experienced Myelodysplastic Syndrome *:

  • female: 62.5 %
  • male: 37.5 %

Age of people who have Polycythemia Vera and experienced Myelodysplastic Syndrome *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 50 %

Common co-existing conditions for these people *:

  1. Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 12.50%
  2. Leukocytosis (increased white blood cells): 1 person, 12.50%

Common drugs taken by these people *:

  1. Revlimid: 5 people, 62.50%
  2. Zofran: 2 people, 25.00%
  3. Nexium: 2 people, 25.00%
  4. Duoneb: 2 people, 25.00%
  5. Aspirin: 2 people, 25.00%
  6. Allopurinol: 2 people, 25.00%
  7. Vidaza: 1 person, 12.50%
  8. Vicodin: 1 person, 12.50%
  9. Thalomid: 1 person, 12.50%
  10. Tamsulosin: 1 person, 12.50%

Common symptoms for these people *:

  1. Fall: 3 people, 37.50%
  2. Disease Progression: 3 people, 37.50%
  3. Enlarged Heart: 2 people, 25.00%
  4. Full Blood Count Abnormal: 2 people, 25.00%
  5. Weakness: 2 people, 25.00%
  6. Alanine Aminotransferase Increased: 2 people, 25.00%
  7. Pneumonia: 2 people, 25.00%
  8. Pain: 2 people, 25.00%
  9. Aspartate Aminotransferase Increased: 2 people, 25.00%
  10. Atelectasis (partial or complete collapse of the lung): 2 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Myelodysplastic syndrome?

Check whether Myelodysplastic syndrome is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Myelodysplastic syndrome:

Common drugs associated with Myelodysplastic syndrome:

All the drugs that are associated with Myelodysplastic syndrome:

Common conditions associated with Myelodysplastic syndrome:

All the conditions that are associated with Myelodysplastic syndrome:

How the study uses the data?

The study is based on Myelodysplastic syndrome and Polycythemia vera, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: